In our June issue, we cover topics such as therapeutic monoclonal antibodies, HPLC-based characterization of virus-like particles, 2D-LC separations, and more. Read our issue content here: https://lnkd.in/e7p9_dmZ
LCGC International’s Post
More Relevant Posts
-
What is epitope binning? Why is it an important step in developing therapeutic monoclonal antibodies? And how can you conduct it? We answer these questions and more in our latest In Focus with Sartorius >>> https://bit.ly/3VphgBN
To view or add a comment, sign in
-
-
Biosimilar Monoclonal Antibodies Market Revenue & Gross Margin, Opportunities, Challenges and Risks Analysis Report 2023-2029 https://lnkd.in/e5asNsG4 #marketanalysis #marketresearch #marketresearchreports #businessintelligence
To view or add a comment, sign in
-
The NEW Thermo Scientific Hypersil GOLD Peptide column demonstrates exceptional capabilities for LC-UV-SQMS monitoring of post-translational modifications in monoclonal antibodies. Learn more by reading the application note: http://spr.ly/6045bU7X3 #CMD #HypersilGOLDPeptide #MonoclonalAntibodies #PostTranslationalModifications #ApplicationNote #ColumnReproducibility #LotToLotReproducibility
To view or add a comment, sign in
-
-
Incorporating the right screening into your antibody development project can make all the difference. If you need a pair of monoclonal antibodies, be sure to include BLI screening to save on time and budget. https://lnkd.in/gUbbuYHA
To view or add a comment, sign in
-
-
Dr. Boothe will discuss how to relate the anatomy of a monoclonal antibody to therapeutic use and describe approaches to improving the safety of monoclonal antibodies. Learn which entities are responsible for approval and adverse event reporting and how that impacts confidence in safety and efficacy. https://lnkd.in/gZkktaG4
To view or add a comment, sign in
-
-
Calcitonin Gene-Related Peptide (#CGRP) Inhibitors such as Gepants and CGRP monoclonal antibodies (CGRP mAbs) are frequently discussed in the #migraine community. Curious about the differences? We've answered the top 15 most frequently asked questions to provide you with important information about these medications. Learn more in our latest blog at https://lnkd.in/eZS-zZWX #MigraineTreatment
To view or add a comment, sign in
-
-
View our on-demand webinar, "The Lumit™ FcRn Binding Immunoassay as a tool in the development of antibody-based therapeutics – Users share their experiences," to learn about: - The principle of Lumit™ Immunoassays and their different formats - How the Lumit™ Immunoassay technology enables fast and easy measurement of FcRn binding - How Lumit™ FcRn Binding Immunoassay compares with SPR analysis - The transferability and reproducibility of the Lumit™ FcRn Binding Immunoassay across different laboratories Register at: https://bit.ly/3JDs1cM
To view or add a comment, sign in
-
-
𝐛𝐢𝐨𝐒𝐞𝐞𝐝𝐢𝐧 𝐍𝐄𝐖 𝐜𝐨𝐥𝐮𝐦𝐧, 𝐭𝐨 𝐬𝐡𝐚𝐫𝐞 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮 𝐭𝐡𝐞 𝐯𝐢𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐭𝐫𝐞𝐧𝐝 𝐨𝐧 𝐭𝐡𝐞 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐓𝐢𝐭𝐥𝐞 𝐟𝐨𝐫 𝐭𝐨𝐝𝐚𝐲’𝐬 𝐚𝐫𝐭𝐢𝐜𝐥𝐞: Junshi Biosciences's Anti-PD-1 Monoclonal Antibody "toripalimab" Approved for Marketing by U.S. FDA Coherus BioSciences Coherus BioSciences and Junshi Biosciences Shanghai Junshi Biosciences Co Ltd announced that the US FDA has approved their monoclonal antibody drug, Loqtorzi (toripalimab, also known as TUOYI® or JS001), in combination with gemcitabine and cisplatin, as a first-line treatment for patients with advanced, recurrent or metastatic nasopharyngeal carcinoma (NPC). The drug has also been approved as a monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy. According to the press release, toripalimab is the first drug approved by the FDA for the treatment of nasopharyngeal carcinoma. For full article, please see the link: https://lnkd.in/gnDASTR6 #china #agreement #monotherapy #treatment #fda
To view or add a comment, sign in
-
-
The NEW Thermo Scientific Hypersil GOLD Peptide column demonstrates exceptional capabilities for LC-UV-SQMS monitoring of post-translational modifications in monoclonal antibodies. Learn more by reading this application note and find out how it has excellent column lot-to-lot reproducibility. http://spr.ly/6047jxAP1 #CMD #HypersilGOLDPeptide #MonoclonalAntibodies #PostTranslationalModifications #ApplicationNote #ColumnReproducibility #LotToLotReproducibility
To view or add a comment, sign in
-
-
Ready to revolutionise the storage of mRNA drugs 🤓
Pleased to announce our participation at the 3rd mRNA Based Therapeutics Summit in Berlin, January 24rd - 25th! Join Joris Lammens and Alain Segers at booth #3 to learn more about the thermostability of mRNA-based drugs. 💉 Don't miss our poster presentation on: “Continuous and controlled lyophilization as a strategy to increase shelf life of mRNA-LNPs”. 📃 Let's connect! Looking forward to meeting you at the conference. 🤝
To view or add a comment, sign in
-